<!DOCTYPE html>

<html lang="en" xml:lang="en">

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />



<title>CONSORT-Statement checklist</title>


<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
      .display.math{display: block; text-align: center; margin: 0.5rem auto;}
  </style>







<link rel="stylesheet" href="docx.css" type="text/css" />




</head>

<body>




<h1 class="title toc-ignore">CONSORT-Statement checklist</h1>



<div id="abstract" class="section level1">
<h1 style = "margin: 24pt 0pt 0pt 0pt;">Abstract</h1>
<p>1a Identification as a randomised trial in the title<br />
1b Structured summary of trial design, methods, results, and conclusions
(for specific guidance see CONSORT for abstracts)</p>
</div>
<div id="introduction" class="section level1">
<h1 style = "margin: 24pt 0pt 0pt 0pt;">Introduction</h1>
<div id="backgroundrationale" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Background/rationale</h2>
<p>Scientific background and explanation of rationale</p>
</div>
<div id="objectives" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Objectives</h2>
<p>Specific objectives or hypotheses</p>
</div>
</div>
<div id="methods" class="section level1">
<h1 style = "margin: 24pt 0pt 0pt 0pt;">Methods</h1>
<div id="trial-design" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Trial design</h2>
<p>Description of trial design (such as parallel, factorial) including
allocation ratio<br />
Important changes to methods after trial commencement (such as
eligibility criteria), with reasons</p>
</div>
<div id="participants" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Participants</h2>
<p>Eligibility criteria for participants<br />
Settings and locations where the data were collected</p>
</div>
<div id="interventions" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Interventions</h2>
<p>The interventions for each group with sufficient details to allow
replication, including how and when they were actually administered</p>
</div>
<div id="outcomes" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Outcomes</h2>
<p>Completely defined pre-specified primary and secondary outcome
measures, including how and when they were assessed<br />
Any changes to trial outcomes after the trial commenced, with
reasons</p>
</div>
<div id="sample-size" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Sample size</h2>
<p>How sample size was determined<br />
When applicable, explanation of any interim analyses and stopping
guidelines</p>
</div>
<div id="randomisation" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Randomisation:</h2>
<div id="sequence-generation" class="section level3">
<h3 style = "margin: 24pt 0pt 0pt 0pt;">Sequence generation</h3>
<p>Method used to generate the random allocation sequence<br />
Type of randomisation; details of any restriction (such as blocking and
block size)</p>
</div>
<div id="allocation-concealment-mechanism" class="section level3">
<h3 style = "margin: 24pt 0pt 0pt 0pt;">Allocation concealment mechanism</h3>
<p>Mechanism used to implement the random allocation sequence (such as
sequentially numbered containers), describing any steps taken to conceal
the sequence until interventions were assigned</p>
</div>
<div id="implementation" class="section level3">
<h3 style = "margin: 24pt 0pt 0pt 0pt;">Implementation</h3>
<p>Who generated the random allocation sequence, who enrolled
participants, and who assigned participants to interventions</p>
</div>
</div>
<div id="blinding" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Blinding</h2>
<p>If done, who was blinded after assignment to interventions (for
example, participants, care providers, those assessing outcomes) and
how<br />
If relevant, description of the similarity of interventions</p>
</div>
<div id="statistical-methods" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Statistical methods</h2>
<p>Statistical methods used to compare groups for primary and secondary
outcomes<br />
Methods for additional analyses, such as subgroup analyses and adjusted
analyses</p>
</div>
</div>
<div id="results" class="section level1">
<h1 style = "margin: 24pt 0pt 0pt 0pt;">Results</h1>
<div id="participant-flow-a-diagram-is-strongly-recommended"
class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Participant flow (a diagram is strongly recommended)</h2>
<p>For each group, the numbers of participants who were randomly
assigned, received intended treatment, and were analysed for the primary
outcome<br />
For each group, losses and exclusions after randomisation, together with
reasons</p>
</div>
<div id="recruitment" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Recruitment</h2>
<p>Dates defining the periods of recruitment and follow-up<br />
Why the trial ended or was stopped</p>
</div>
<div id="baseline-data" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Baseline data</h2>
<p>A table showing baseline demographic and clinical characteristics for
each group</p>
</div>
<div id="numbers-analysed" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Numbers analysed</h2>
<p>For each group, number of participants (denominator) included in each
analysis and whether the analysis was by original assigned groups</p>
</div>
<div id="outcomes-and-estimation" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Outcomes and estimation</h2>
<p>For each primary and secondary outcome, results for each group, and
the estimated effect size and its precision (such as 95% confidence
interval)<br />
For binary outcomes, presentation of both absolute and relative effect
sizes is recommended</p>
</div>
<div id="ancillary-analyses" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Ancillary analyses</h2>
<p>Results of any other analyses performed, including subgroup analyses
and adjusted analyses, distinguishing pre-specified from exploratory</p>
</div>
<div id="harms" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Harms</h2>
<p>All important harms or unintended effects in each group (for specific
guidance see CONSORT for harms)</p>
</div>
</div>
<div id="discussion" class="section level1">
<h1 style = "margin: 24pt 0pt 0pt 0pt;">Discussion</h1>
<div id="limitations" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Limitations</h2>
<p>Trial limitations, addressing sources of potential bias, imprecision,
and, if relevant, multiplicity of analyses</p>
</div>
<div id="generalisability" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Generalisability</h2>
<p>Generalisability (external validity, applicability) of the trial
findings</p>
</div>
<div id="interpretation" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Interpretation</h2>
<p>Interpretation consistent with results, balancing benefits and harms,
and considering other relevant evidence</p>
</div>
</div>
<div id="other-information" class="section level1">
<h1 style = "margin: 24pt 0pt 0pt 0pt;">Other information</h1>
<div id="registration" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Registration</h2>
<p>Registration number and name of trial registry</p>
</div>
<div id="protocol" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Protocol</h2>
<p>Where the full trial protocol can be accessed, if available</p>
</div>
<div id="funding" class="section level2">
<h2 style = "margin: 24pt 0pt 0pt 0pt;">Funding</h2>
<p>Sources of funding and other support (such as supply of drugs), role
of funders</p>
</div>
</div>



<!-- code folding -->



</body>
</html>
